Skip to content
‹ Back to IndustriesHealthcare

Navigating COVID-19 and Other Disruptors with Proactive Performance Analysis

During a pandemic like the one currently brought on by COVID-19, much of your attention is rightly focused on how you can best respond to the challenges presented by increased patient volumes and supply chain breakdowns. However, while documentation and coding may be back-of-mind at the moment, you can only truly assess how your hospital…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share
Navigating COVID-19 and Other Disruptors with Proactive Performance Analysis

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

During a pandemic like the one currently brought on by COVID-19, much of your attention is rightly focused on how you can best respond to the challenges presented by increased patient volumes and supply chain breakdowns. However, while documentation and coding may be back-of-mind at the moment, you can only truly assess how your hospital and staff are performing and drive immediate change by accurately and proactively capturing your data.

“As we know, the ability to analyze performance is only as good as the underlying data itself. So, it’s important organizations are diligent now so that there are trustworthy insights down the road to use as a tool to learn and improve into the future,” said Lindsey Klein, General Manager and driving force behind Quantros’ data analytics tool’s evolution.

Attention to detail and thorough coding work now will prepare you for disruptions in the future and allow you to both gain valuable insights from this pandemic and mitigate potential long-term effects of this crisis.

Being Proactive in the Absence of an ICD-10 Code for COVID-19

The novel coronavirus currently spreading across the globe is officially labeled “severe acute respiratory syndrome coronavirus 2,” or SARS-CoV-2.

By extension, COVID-19 refers to all respiratory infections brought on by contraction of SARS-CoV-2.

The Centers for Disease Control and Prevention (CDC) published the final guidelines for the new diagnosis code U07.1, COVID-19, effective April 1 to September 30, 2020, and ensuring you’re correctly classifying patients, and that the data you collect from this period is actionable and beneficial upon review, is critical.

While the official ICD-10 code is crucial moving forward, there are numerous other measures hospitals should be taking to ensure accurate data for both reporting and future analysis.

“To get a true understanding of performance during this pandemic with both COVID and non-COVID populations we recommend that organizations go back to cases before the formal code was released on April 1st and re-code/re-bill those cases using the new code,” said Lindsey Klein.

Additional measures that will aid hospitals and health systems in capturing a complete picture of their performance during this time include:

  • New codes for Confirmed Exposure (Z20.828), Possible Exposure Ruled Out (Z03.828) and COV-19 testing (CPT code 87635) are integral for tracking the spread of the disease and analyzing the success of containment measures
  • CPT codes 94001-94005 help track the demand for ventilators among COVID patients
  • Capture co-morbid and chronic conditions in addition to demographic and social determinants to allow you to conclude which patient populations were truly the most vulnerable and where mortality and complication risks were greatest

Acting Now to Boost Response to Ripple Effects of COVID-19 and Future Disruptions

Documenting and coding in a way that will make sense upon review as the pandemic’s impact recedes, means you can ensure that you’re taking appropriate steps to not lose sight of the larger picture in the wake of increased demand and stressors brought on by the disease. Considering questions surrounding the direct effect of COVID-19, can also help you gain true understanding of the totality of your operations and care during this uncertain time.

Those questions include:

  • Which populations were most affected by the virus, and could we have done anything to adjust care to improve their outcomes?
  • What steps are we taking to provide pre-pandemic levels of care for patients with other diagnoses – cardiac patients, stroke victims, etc. – during this time? Are they enough?
  • Are we working with an eye toward the long-term or simply trying to keep up with the current pace of the spread of COVID-19?
  • How many resources (of various types) did we use, and how many of those resources do we need to keep moving forward?
  • Did telehealth play a positive role in our response and, if so, what is our approach to telehealth as a more widespread patient option moving forward?
  • What could be the consequences for patient of delaying elective procedures, and how do we prevent those patients from having poor outcomes once we resume elective operations?

Being diligent now will enable you to assess your response to this pandemic through critical coding data and reporting, to in turn, ease the potential damage left in the wake of this period.

Prepping for the “New Normal”

Many agree – there will be no “back to normal” once this crisis is over. The COVID-19 pandemic will likely catalyze and accelerate the long anticipated “transformation of healthcare.”

However, rapid change can be viewed as positive. The healthcare industry and its regulators are aggressively adopting a contemporary service mindset and the modern tools and technologies that come with it. While the catalyst for this overhaul is certainly a frightening one, the end result could be a system more ready to act the next time something of this scale occurs.

Consider how hospitals adapt to hurricanes and other natural disasters. Once the immediate threat has passed, collaboration, careful study, and accelerating the implementation of strategies on a hospital-by-hospital, regional, and national basis help healthcare systems be more prepared for future emergencies.

The healthcare system’s continued march toward telehealth, predictive analytics, beneficial and actionable data analysis, and the sharing of that data is going to be accelerated by the collective response to COVID-19, and, by being diligent, you can do your part to ensure that change is a lasting one.

Quantros Is Ready to Partner with You in Being Agile and Proactive

Quantros understands the lasting impact on your data, performance, and system this pandemic will have, and we’re actively working to deliver beneficial solutions as quickly as possible.

We’re currently working to build increased functionality into our industry-leading solution, helping you achieve not only better care now, but key insights that will promote agility in the face of similar challenges in the future.

“It’s is unclear today exactly how COVID-19 will change healthcare in the US or globally. In the short term, it will clearly stress the US healthcare system’s capacity and strain hospital systems financially. We may see smaller health systems unable to weather the storm. Longer term, the healthcare system will need to develop better pandemic readiness. It is unclear how much of that can, and will, be solved for by the private sector vs the government. One thing is clear, some things will never be the same,” Trey Cook, Quantros CEO weighed in.

Documentation and coding may not be your first priority as you attempt to mitigate the ripple effects of COVID-19, but it’s a vital linchpin in correctly evaluating where your hospital ranks and ensuring you don’t experience lingering repercussions associated with less-than-optimal outcomes during tumultuous times.

To learn more about how Quantros is committed to helping you accomplish those key goals, contact us today.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Why MVP wants to push fresher care-gap data into EMRs

Why MVP wants to push fresher care-gap data into EMRs

MVP Health Care, a nonprofit insurer in New York and Vermont, built Arcadia-based provider dashboards that combine ADT alerts, care gaps, utilization and pharmacy data. Timing drives the design. Its next step, delivering care gaps inside provider EMRs, should move fastest with practices that already exchange data through Arcadia.

  • 01For a quality measure on a seven-day clock, a payer report that runs a few months behind arrives after the deadline it was meant to help with.
  • 02The quickest EMR integrations for a regional payer are likely with practices already sharing data on the same platform through Medicare ACOs or other payers. Practices new to that kind of exchange need trust built in both directions first.
  • 03A useful test for any payer’s provider analytics: does a service completed last week drop off the care-gap list, or does the practice still call the patient again?

Nov 13, 2026

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

BlackRock's $2.8 billion buys majority ownership of a joint venture holding about 150 CenterWell clinics, replacing WCAS as Humana's outside investor. CenterWell keeps a minority stake and keeps running the clinics. The terms set a timeline: two years of expected growth spending, an option for Humana to buy clinics back from 2028, and a BlackRock right to start a sale of any clinics still in the venture at the end of 2033, with CenterWell getting the first offer. The deal is expected to close in the fourth quarter, subject to regulatory approvals.

  • 01BlackRock's $2.8 billion buys majority ownership of about 150 CenterWell clinics, while Humana keeps day-to-day management and an option to repurchase clinics starting in 2028.
  • 02The 2028 buyback and 2033 sale terms apply to the roughly 150 clinics in the new joint venture. CenterWell Senior Primary Care runs 250 clinics in total.
  • 03The deal’s lower-cost-of-capital claim will be tested after closing—first by how the venture deploys new capital over the next two years to support clinics, open locations and pursue acquisitions, and then by Humana’s 2028 decision on whether to start buying clinics back.

Nov 12, 2026

Healthcare AI should give doctors attention back, not shorter visits

Healthcare AI should give doctors attention back, not shorter visits

Healthcare organizations should deploy AI to give clinicians back attention and capacity for better decisions, not simply shorten visits. Landry argues AI should fit into existing workflows with insights appearing at the right time, and that organizations should set clear governance and automation boundaries before deployment and measure what changes for patients, clinicians and the organization.

  • 01AI success in healthcare should expand clinician capacity for thoughtful care, not optimize for visit speed; a three-minute appointment is not patient-centered innovation.
  • 02Design AI into workflows clinicians already use with insights appearing at the right moment, making adoption a workflow problem rather than a training problem.
  • 03Set automation boundaries before deploying AI, specifying what it may do alone, what it recommends for clinician decision-making, and what requires explicit human control and accountability.

Nov 11, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512